SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-15-023033
Filing Date
2015-04-15
Accepted
2015-04-15 17:12:42
Documents
2
Group Members
ARTHUR COHENHEALTHCOR ASSOCIATES, LLCHEALTHCOR GROUP, LLCHEALTHCOR LONG MASTER GP, LLCHEALTHCOR LONG OFFSHORE MASTER FUND, L.P.HEALTHCOR OFFSHORE GP, LLCHEALTHCOR OFFSHORE MASTER FUND, L.P.JOSEPH HEALEY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v407337_sc13g.htm SC 13G 127768
2 EXHIBIT 1 v407337_ex-1.htm EX-99.1 13192
  Complete submission text file 0001144204-15-023033.txt   142916
Mailing Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 43RD FLOOR NEW YORK NY 10019 212-622-7731
HealthCor Management, L.P. (Filed by) CIK: 0001343781 (see all company filings)

IRS No.: 202893581 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Subject) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87858 | Film No.: 15772416
SIC: 2834 Pharmaceutical Preparations